Search
for
Sort by
Research 121–150 of 328
- Modern Therapies for Discoid Lupus Erythematosus: A Narrative Review
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Poster Presentations at the 28th Joint Meeting of the International Society of Dermatopathology, March 5–6, 2025, Orlando, Florida, USA
- Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities
- Repurposed Drugs: Current Trends in Drug Discovery
- Stem-cell therapy in dermatology – Challenges and opportunities
- Refractory Myasthenia Gravis and Concurrent Alopecia Areata Postthymectomy With Improvements After Cortisone Taper: A Case Report
- Dermatologic manifestations of thyroid disease: a literature review
- CAQ Corner: Basic concepts of transplant immunology
- Subject Index
- Subject Index
- Diverse Role of OX40 on T Cells as a Therapeutic Target for Skin Diseases
- Small extracellular vesicles from mesenchymal stem cells: A potential Weapon for chronic non-healing wound treatment
- Trastuzumab Induced Chemobrain, Atorvastatin Rescued Chemobrain with Enhanced Anticancer Effect and without Hair Loss-Side Effect
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Transcriptome Meta-Analysis Confirms the Hidradenitis Suppurativa Pathogenic Triad: Upregulated Inflammation, Altered Epithelial Organization, and Dysregulated Metabolic Signaling
- Diabetes mellitus: interdisciplinary medical, surgical and psychological therapeutic approach
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- The Chemical and Pharmacological Research Progress on a Kind of Chinese Herbal Medicine, Fructus Malvae
- TRANSMEDCON 2022: E-Poster Abstracts
- https://researchopenworld.com/genetics-of-hidradenitis-suppurativa/#
- Author Index
- Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing—A Molecular Meta-Analysis
- The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds
- Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndrome
- Severe steroid-dependent idiopathic angioedema with response to rituximab
- Alopecia Universalis in a Multiple Sclerosis Patient After Switching From Rituximab to Ocrelizumab: A Case Report
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis